BarbaraM.WirostkoMD

PubMed

• Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
  Horns, J., Polski, A., Liu, K., Gupta, D., Grewal, D., Wirostko, B., Stagg, B.> ;BMJ Open Ophthalmology. 2023 Dec 22
• 12 citations
  The Use of ChatGPT to Assist in Diagnosing Glaucoma Based on Clinical Case Reports.
  Mohammad Delsoz, Hina Raja, Yeganeh Madadi, Anthony A Tang, Barbara M Wirostko, Malik Y Kahook, Siamak Yousefi> ;Ophthalmology and Therapy. 2023 Dec 1
• Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent.
  Uttio Roy Chowdhury, Cynthia L Pervan-Steel, Ryan Sheeler, Hemchand K Sookdeo, Brian Rogers, Ralph Casale, Peter I Dosa, Thurein Htoo, Barbara M Wirostko, Michael P Fa...> ;Journal of Ocular Pharmacology and Therapeutics. 2023 Jun 1
• Abdominal aortic aneurysm and exfoliation syndrome in Utah.
  Ayesha Patil, Matthew Conley, Christian Pompoco, Chase Paulson, Samuel Taylor, Cole Swiston, Jennifer S Herrick, Robert Ritch, Karen Curtin, Barbara Wirostko> ;Acta Ophthalmologica. 2023 Jun 1
• Abdominal aortic aneurysm and exfoliation syndrome: A literature review comparing single site findings.
  Ayesha Patil, Matthew Conley, Chase Paulson, Christian Pompoco, Ryan Wallace, Cole Swiston, Robert Ritch, Karen Curtin, Barbara Wirostko> ;Acta Ophthalmologica. 2023 Aug 1
• The utility of home tonometry for peri-interventional decision-making in glaucoma surgery: Case series.
  Ariana M Levin, Elyse J McGlumphy, Craig J Chaya, Barbara M Wirostko, Thomas V Johnson> ;American Journal of Ophthalmology Case Reports. 2022 Dec 1
• 3 citations
  Exfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation.
  Ayesha Patil, Cole Swiston, Ryan T Wallace, Chase Paulson, Matthew E Conley, Lori McCoy, Craig Chaya, Barbara Wirostko> ;Vision. 2022 Oct 3
• 1 citations
  Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population.
  Jack E Geduldig, Erica B Jacobs, Tak Yee T Tai, Sumayya Ahmad, Nisha Chadha, Douglas F Buxton, Kateki Vinod, Barbara M Wirostko, Jae H Kang, Janey L Wiggs, Robert Ritc...> ;Ophthalmology. Glaucoma. 2022 Apr 22
• 1 citations
  Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug.
  Cynthia L Pervan-Steel, Uttio Roy Chowdhury, Hemchand K Sookdeo, Ralph A Casale, Peter I Dosa, Thurein M Htoo, Michael P Fautsch, Barbara M Wirostko> ;Investigative Ophthalmology & Visual Science. 2022 Apr 1
• 3 citations
  Exfoliation Syndrome in Baja Verapaz Guatemala: A Cross-Sectional Study and Review of the Literature.
  Chase Paulson, Samuel C Thomas, Orlando Gonzalez, Samuel Taylor, Cole Swiston, Jennifer S Herrick, Lori McCoy, Karen Curtin, Craig J Chaya, Brian C Stagg, Barbara M Wi...> ;Journal of Clinical Medicine. 2022 Mar 24
• 6 citations
  Risk of atrial fibrillation is increased in patients with exfoliation syndrome: the Utah project on exfoliation syndrome (UPEXS).
  Barbara M Wirostko, Karen Curtin, Samuel C. Taylor, Chase Paulson, Christian James Pompoco, Brian M. Besch, Ravi Ranjan, Robert Ritch> ;Acta Ophthalmologica. 2021 Sep 21
• 20 citations
  Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations.
  Ariana M Levin, Craig J. Chaya, Malik Y. Kahook, Barbara M Wirostko> ;Journal of Glaucoma. 2021 Jun 4
• 1 citations
  Home-Based Intraocular Pressure Measurements: Tracing a Parallel with Out-of-Office Blood Pressure Measurement.
  Ariana M Levin, Daniel Vezina, Barbara M Wirostko> ;Ophthalmology. Glaucoma. 2021 May 1
• 7 citations
  Reversible HER2 antibody-drug conjugate-induced ocular toxicity.
  Anushree Sharma, Kamran M Riaz, Mohsain Gill, Amita Patnaik, Susanna Varkey Ulahannan, Judy S. Wang, Dan S. Gombos, Qiuqing Ang, Dragan Cicic, Gregory Bergonio, Cong Z...> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2021 Mar 13
• 6 citations
  Summary of Utah Project on Exfoliation Syndrome (UPEXS): using a large database to identify systemic comorbidities
  Christian James Pompoco, Karen Curtin, Samuel C. Taylor, Chase Paulson, Caleb Shumway, Matt Conley, D James Barker, Cole Swiston, Brian C. Stagg, Robert Ritch, Barbara...> ;BMJ Open Ophthalmology. 2021 Oct 27
• 9 citations
  Special Commentary: Using Clinical Decision Support Systems to Bring Predictive Models to the Glaucoma Clinic
  Brian C. Stagg, Joshua D. Stein, Felipe A. Medeiros, Barbara M Wirostko, Alan S. Crandall, M. Elizabeth Hartnett, Mollie R. Cummins, Alan H. Morris, Rachel Hess, Kensa...> ;Ophthalmology. Glaucoma. 2021 Jan 1
• 1 citations
  Novel Cross-Linked Ocular Bandage Gel Improves Reepithelialization After Photorefractive Keratectomy: A Randomized, Masked Prospective Study.
  Darcy Wolsey, Stephen G. Slade, Barbara M Wirostko, Lisa A Brandano, Brenda K. Mann, Daniel S. Durrie, Vance Thompson> ;Journal of Ocular Pharmacology and Therapeutics. 2020 Oct 5
• 6 citations
  Association between Obstructive Sleep Apnea and Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome.
  Caleb Shumway, Karen Curtin, Samuel C. Taylor, Krishna M. Sundar, Barbara M Wirostko, Robert Ritch> ;Ophthalmology. Glaucoma. 2021 May 1
• Endothelial Cells Count: The Importance of Monitoring Corneal Endothelium When Approving New Ocular Medications and Devices
  Marshall J. Huang, Barbara M Wirostko> ;Ophthalmology. Glaucoma. 2020 Jul 29
• 4 citations
  Cohort Study of Nonmelanoma Skin Cancer and the Risk of Exfoliation Glaucoma.
  Jae H Kang, Trang VoPham, Francine Laden, Bernard A Rosner, Barbara Wirostko, Robert Ritch, Janey L Wiggs, Abrar Qureshi, Hongmei Nan, Louis R Pasquale> ;Journal of Glaucoma. 2020 Jun 1
• Response to: Management of Glaucoma in Pregnancy.
  Sunu Mathew, Alon Harris, Colin Ridenour, Barbara M Wirostko, Kendall M. Burgett, Molly D. Scripture, Brent Siesky> ;Journal of Glaucoma. 2020 Apr 1
• 22 citations
  Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications.
  Barbara M Wirostko, Michael Korenfeld, Stephen From, Michael B. Raizman, Victor L. Perez> ;Journal of Ocular Pharmacology and Therapeutics. 2020 Mar 4
• 9 citations
  Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
  John D. Sheppard, Sunir J. Garg, Christopher Lievens, Lisa A Brandano, Barbara M Wirostko, Michael S Korenfeld, Michael B. Raizman, C. Stephen Foster> ;American Journal of Ophthalmology. 2020 Mar 1
• Response.
  Mathew, S., Harris, A., Ridenour, C. M., Wirostko, B. M., Burgett, K. M., Scripture, M. D., Siesky, B.> ;Journal of glaucoma. 2020 Jan 29
• 1 citations
  Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. (J Ocul Pharmacol Ther 2019;35(7):381-387).
  Barbara M Wirostko, Brenda K. Mann, Darren L. Stirland> ;Journal of Ocular Pharmacology and Therapeutics. 2020 Jan 22
• Join now to see all

Journal Articles

• Association of Exfoliation Syndrome with Risk of Indirect Inguinal HerniaThe Utah Project on Exfoliation Syndrome  
  R Rand Allingham, Barbara M Wirostko, Robert Ritch, JAMA
• Novel therapy to treat corneal epithelial defects; a hypothesis with growth hormone  
  Wirostko B, Rafii MJ, Sulivan D, Morelli J, Ding J, The Ocular Surface, 1/1/2014
• Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel  
  Wirostko B, Mann B, Williams D. Prestwich G, Advanced Wound Care, 1/1/2014
• Human Growth Hormone Promotes Corneal Epithelial Cell Migration in Vitro  
  Ding J, Wirostko B, Sullivan D, Cornea, 1/1/2014
• Systemic Diseases Associated with Pseudoexfoliative Syndrome  
  Bettis DI, Allingham RR, Wirostko BM, International Ophthalmology Clinics, 1/1/2014
• Ocular hypertension following intravitreal anti-vascular endothelial growth factor therapy: review of the literature and possible role of nitric oxide  
  Morshedi G, Ricca A, Wirostko B, Journal of Glaucoma, 1/1/2014
• Upper limits of intraocular pressure in glaucoma clinical trials  
  DeMill DL, Wirostko BM, Nelson LA, Stewart WC, Clin Experiment Ophthalmol, 1/1/2014
• Thiolated hyaluronan-based hydrogels crosslinked using oxidized glutathione: an injectable matrix designed for ophthalmic applications  
  Zarembinski T, Doty NJ, Erickson IE, Srinivas R, Wirostko BM, Tew WP, Acta Biomater, 1/1/2014
• Cerebral blood flow in glaucoma patients  
  Harris A, Wirostko B, J Glaucoma, 1/1/2013
• Contrast sensitivity basics and a critique of currently available tests  
  Richman J, Spaeth GL, Wirostko B, J Cataract Refract Surg, 1/1/2013
• Review of the Influence of Pigment Dispersion and Exfoliation Glaucoma Diagnosis on Intraocular Pressure in Clinical Trials Evaluating Primary Open-angle Glaucoma and ...  
  William C. Stewart,; David L. DeMill, BA; Barbara M. Wirostko MD; Lindsay A. Nelson,BS; Jeanette A. Stewart, RN, J Glaucoma, 1/1/2013
• Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges  
  Molokhia S, Thomas S, Garff K, Mandell K, Wirostko B, J Ocular Pharm and Therap, 1/1/2013
• The role of transforming growth factor Beta in glaucoma and the therapeutic implications  
  Mark A Prendes, Alon Harris, Barbara M Wirostko, Austin L Gerber, Brent Siesky, Br J Ophthalmol, 1/1/2013
• Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma  
  Yochai Z. Shoshani, Alon Harris, Mohammadali M. Shoja, Deepam Rusia, Brent Siesky, Yoel Arieli, and Barbara Wirostko, Curr Eye Res, 1/1/2012
• Average eye versus highest intraocular pressure analyses in glaucoma clinical trials  
  D. L. DeMill, BA, Barbara M. Wirostko, MD, Lindsay A. Nelson, BS, Jeanette A. Stewart, RN, William C. Stewart, MD, Ophthalmic Res, 1/1/2012
• Impaired ocular blood flow regulation in patients with open angle glaucoma and diabetes  
  Shoshani Y, Harris A, Shoja MM, Arieli Y, Ehrlich R, Primus S, Ciulla T, Cantor A, Wirostko B, Siesky BA, Clin Experiment Ophthalmol, 1/1/2012
• Ocular Drug Delivery for Glaucoma Management  
  Nathan Gooch, Sarah A. Molokhia, Russell Condie, R.M. Burr, Bonnie Archer, Balamurali K. Ambati, and Barbara Wirostko, Pharmaceutics, 1/1/2012
• Contrast sensitivity, ocular blood flow and their potential role in assessing ischemic retinal disease  
  Yochai Z. Shoshani, Alon Harris, Deepam Rusia, George Spaeth, Brent Siesky, Ayala Pollack, Barbara Wirostko, Acta Ophthalmologica, 1/1/2011
• The effect of Pegaptnib (Macugen) injection on retinal and retrobulbar blood flow in retinal ischemic disease  
  Shoshani Y, Harris A, Ehrlich R, Yung C, Peracha M, Rusia D, Pollack A, Wirostko B, Siesky B, Retina, 1/1/2011
• Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature  
  Tressler C, Wiseman R, Dombi T, Jessen B, Huang K, Kwok K, Wirostko B, British J Ophthalmology, 1/1/2011
• Patient Preferences in the Treatment of Diabetic Retinopathy  
  Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A, Patient Preference and Adherence, 1/1/2011
• Rho Kinase Inhibitors for Treatment of Glaucoma  
  Mandell KJ, Kudelka MR, Wirostko B, Expert Review, 1/1/2011
• Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study  
  Maeda-Chubachi T, MD, PhD, Chi-Burris K, MPH, Simons B,MD, PhD, Freedman S, MD, Khaw P, MD, PhD, Wirostko B, MD, Yan E, PhD, for the A6111137 Study Group, Ophthalmology, 1/1/2011
• Latanoprost Systemic Exposure in Pediatric and Adult Glaucoma Patients: A Phase I Open label Study  
  Susan Raber, PharmD, Rachel Courtney, PhD, Tomoko Maeda-Chubachi, MD, PhD, Brad D. Simons, MD, PhD, Sharon F. Freedman, MD, Barbara Wirostko, MD, for the A6111139 Stud..., Ophthalmology, 1/1/2011
• Patient Preferences for Diabetic Retinopathy Health States  
  Szabo, S, Pleil, A, Wirostko, B et al, Invest Ophthalmol Vis Sci, 1/1/2010
• Join now to see all

Lectures

• Delivery of Human Growth Hormone via DSM's Poly(ester amide) 
  Seattle, WA - 1/1/2013
• Corneal Wound Healing Model in New Zealand White Rabbits for Evaluating Persistent Corneal Epithelial Defects 
  Seattle, WA - 1/1/2013
• Hystem, a bio-absorbable protein delivery polymer: safety, and efficacy in a corneal debridement model 
  Seattle, WA - 1/1/2013
• Systemic Blood Pressure and Ocular Perfusion Pressure Affects Blood Flow to the Optic Nerve Head in Glaucoma Patients with Diabetes 
  Seattle, WA - 1/1/2013
• Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS8535 in vivo 
  Fort Lauderdale, Florida - 1/1/2012
• Changes in Retrobulbar Blood Flow over Time in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Changes in Retinal Capillary Blood Flow are Related to Changes in Optic Nerve Structure in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Baseline Retrobulbar Blood Flow is Predictive of Macular Thickness in Patients with Glaucoma 
  Fort Lauderdale, Florida - 1/1/2012
• Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys 
  Fort Lauderdale, Florida - 1/1/2011
• Pharmaceutical Profile of A Novel Rho Kinase (ROCK) Inhibitor ATS907 For Reduction Of IOP In Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Tolerability and IOP Lowering Activity of a Topical Rho Kinase Inhibitor, ATS907, in Normotensive Rabbits 
  Fort Lauderdale, Florida - 1/1/2011
• Conjugation of Gadolinium Based Contrast Agent to Avastin for Pharmacokinetics with MRI 
  Fort Lauderdale, Florida - 1/1/2011
• Retinal Microcirculation As A Predictor For Retinal And Optic Nerve Structural Changes In Patients With Primary Open Angle Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Decreasing Retrobulbar Blood Flow is Predictive of OCT Structural Changes in Patients with Primary Open Angle Glaucoma 
  Fort Lauderdale, Florida - 1/1/2011
• Clinical Research & Development 
  University of Utah. SLC, Utah - 1/1/2011
• Latanoprost (LAT) in Pediatric Glaucomas: Pharmacokinetics (PK)/Safety Evaluation and Phase 3 Study vs Timolol (TIM) 
  Chicago IL - 1/1/2010
• PANDA Study Group. Comparison of Latanoprost and Timolol in Pediatric Glaucoma Patients: a Phase 3, 12-week, Double-Masked Multicenter Study 
  Berlin Germany - 1/1/2010
• Malignant Melanoma and the Use of Latanoprost: A Risk Assessment 
  Berlin Germany - 1/1/2010
• Systemic Exposure and Safety of Latanoprost 0.005% in Infants with Glaucoma 
  Berlin Germany - 1/1/2010
• Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension: Ocular Safety 
  Berlin Germany - 1/1/2010
• Pharmacokinetics (PK) of Latanoprost Acid in Pediatric and Adult Glaucoma Patients Treated with Latanoprost 0.005% 
  Fort Lauderdale, Florida - 1/1/2010
• A systematic review and meta-analysis of literature from 1975 to 2008 demonstrating reduced diabetic retinopathy progression rates 
  Nice France - 1/1/2009
• Patient Preferences in the Treatment of Diabetic Retinopathy 
  Fort Lauderdale, Florida - 1/1/2009
• Characterizing Functional Limitations for Adults with Diabetic Retinopathy 
  1/1/2009
• The Effect of Treatment Modality on Structural and Functional Changes over 82 Weeks in Patients with Diabetic Macular Edema (DME) 
  Hong Kong - 1/1/2008
• Join now to see all